Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02801747 · ClinicalTrials.gov registry record · NA
Using MOST to Optimize an HIV Care Continuum Intervention for Vulnerable Populations
A NA study, sponsored by New York University.
- Completed
- Registry status
- NA
- Development phase
- 512
- Enrollment target
NCT02801747 is a NA study that has completed, run by New York University. The registered enrollment target is 512 participants.
The verdict
NCT02801747, a NA study, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- NA
- Development phase
- 512 participants
- Enrollment target
Study Summary
The present study targets the large population of persons living with HIV/AIDS (PLHA) in the U.S. who are both insufficiently engaged in HIV primary care and not taking antiretroviral therapy (ART), who are mainly African American/Black and Latino. NIH has emphasized the urgent need for new research approaches to advance intervention science, and the proposed project employs a new, potent, and innovative research methodology, the Multiphase Optimization STrategy (MOST), a framework for developing highly efficacious, efficient, scalable, and cost-effective interventions. The proposed study has the highest public health significance: it addresses a vulnerable population of PLHA, including the critically important subpopulations of men who have sex with men (MSM) and substance users; will develop an efficient and cost effective intervention to increase engagement along the HIV care continuum for these vulnerable groups; and addresses two areas highlighted in the August 2015 notice on research priorities from the NIH Office of AIDS Research (NOT-OD-15-137), namely, engaging PLHA in prevention/treatment services, and reducing HIV/AIDS-related racial/ethnic disparities.
Interventions
- BEHAVIORAL Heart to Heart2 (HTH2)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 512 participants |
| Start Date | 2017-03-20 |
| Est. Completion | 2022-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02801747
The ClinicalTrials.gov registry entry for NCT02801747 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 512 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Heart to Heart2 (HTH2) is the first listed.
NCT02801747 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02801747 about?
NCT02801747 is a clinical study titled "Using MOST to Optimize an HIV Care Continuum Intervention for Vulnerable Populations". The present study targets the large population of persons living with HIV/AIDS (PLHA) in the U.S. who are both insufficiently engaged in HIV primary care and not taking antiretroviral therapy (ART), who are mainly African American/Black and Latino. NIH has emphasized the urgent need for new research...
What is the current status of trial NCT02801747?
This trial is currently completed. It is a NA study. The enrollment target is 512 participants. The study started on 2017-03-20. Estimated completion is 2022-07-15.
What interventions are being tested in trial NCT02801747?
The interventions under investigation include: Heart to Heart2 (HTH2) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02801747?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.